A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Rational Vaccines

Status: Completed

Conditions: Genital Herpes; Patient Engagement

Study type: Observational

Funder types: Industry

Identifiers

NCT05500053

RVx-001-PSS

Details and patient eligibility

About

Determine the baseline characteristics of patients who have recurrent symptomatic genital herpetic disease Determine the acceptance to patients of clinical trial procedures Determine interest in participation in genital herpes vaccine trials

Enrollment: 68 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Able to understand and willing to sign the informed consent document.
• Patient confirmation of a diagnosis of HSV-2 infection at least 2 years prior to inclusion. Laboratory confirmation is not required.
• Symptomatic recurrent genital herpetic disease for >2 years supported by compatible clinical history

Exclusion criteria

• Subjects who do not meet the inclusion criteria for the study
• Subjects who are unable to provide legally effective informed consent